We are monitoring the impact of COVID-19 on Middle East & Africa Injectable Drug Delivery Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2021
Share on
Share on

Middle East & Africa Injectable Drug Delivery Market Research Report – Segmented By Device Type, Formulation, Therapeutic Use, End User, & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, Forecast, Growth | 2019 - 2024

Pulished: February, 2020
ID: 2021
Pages: 145

Middle East & Africa Injectable Drug Delivery Market Size & Growth (2019 – 2024):

The Size of the Middle East and Africa Injectable Drug Delivery Market is valued at USD 3594.9 Million in 2019 and estimated to be growing at a CAGR of 11.93%, to reach USD 6317.4 Million by 2024 during the forecast period 2019-2024.

Injectable drug delivery technologies allow the transport of drugs detailed in fluid form and encourage the fast transport of the drug into the body. It likewise helps in managing drugs in comatose and unconscious patients. These delivery frameworks are generally accepted because of their recognition of a faster onset reaction with high adequacy.

The major factors which drive the market growth are increasing demand and technological advances for devices. The major limitations are infections and injuries due to Injectables and regulatory framework issues.

Middle East & Africa Injectable Drug Delivery Market has been segmented and sub-segmented into the following categories:

  • By Device Type: Self-Injection Devices, Conventional Devices.
  • By Formulation: Conventional Drug Delivery, Novel Drug Delivery.
  • By Therapeutic use: Autoimmune Disorders, Hormonal Disorders, Oncology.
  • By End User: Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories.
  • By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Noteworthy Companies leading the Middle East & Africa Injectable drug delivery market profiled In the report are Antares Pharmaceuticals Ltd, Baxter International, Becton Dickinson Company, Elcam Medical, Eli Lily and Company, Unilife Corporation and West Pharmaceutical Inc

1.Introduction              

                1.1 Market Definition

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods      

                1.4 General Study Assumptions  

2. Research Methodology                       

                2.1 Introduction           

                2.2 Research Phases  

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design     

                2.4 Study Timeline      

3. Overview                   

                3.1 Executive Summary  

                3.2 Key Inferences     

                3.3 Epidemology          

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                

                4.1 Market Drivers      

                4.2 Market Restraints

                4.3 Key Challenges     

                4.4 Current Opportunities in the Market          

5. Market Segmentation                          

                5.1 Device Type           

                                5.1.1 Introduction                                           

                                5.1.2 Self-injection Devices                                         

                                5.1.3  Conventional Devices                                        

                                5.1.4  Y-o-Y Growth Analysis, By Device Type                                      

                                5.1.5  Market Attractiveness Analysis, By Device Type                                    

                                5.1.6  Market Share Analysis, By Device Type                                     

                5.2 Formulation           

                                5.2.1 Introduction                                           

                                5.2.2 Conventional Drug Delivery                                             

                                5.2.3  Novel Drug Delivery                                           

                                5.2.4 Y-o-Y Growth Analysis, By Formulation                                       

                                5.2.5 Market Attractiveness Analysis, By Formulation                                     

                                5.2.6 Market Share Analysis, By Formulation                                      

                5.3 Therapeutic Use   

                                5.3.1 Introduction                                           

                                5.3.2 Autoimmune Disorders                                     

                                5.3.3 Hormonal Disorders                                            

                                5.3.4 Oncology                                 

                                5.3.5 Y-o-Y Growth Analysis, By Therapeutic Use

                                5.3.6  Market Attractiveness Analysis, By Therapeutic Use                                           

                                5.3.7  Market Share Analysis, By Therapeutic Use                                             

                5.4 End-user

                                5.4.1 Introduction                                           

                                5.4.2 Hospitals                                  

                                5.4.3 Homecare Settings

                                5.4.4 Research Institutes                                             

                                5.4.5 Clinical Laboratories                                            

                                5.4.6 Other                                        

                                5.4.7 Y-o-Y Growth Analysis, By End-user

                                5.4.8  Market Attractiveness Analysis, By End-user

                                5.4.9  Market Share Analysis, By End-user

6. Geographical Analysis                          

                6.1 Introduction           

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

  6.1.3.1 By Geographical Area                     

  6.1.3.2 By Device Type                  

  6.1.3.3 By Formulation                  

  6.1.3.4 By Therapeutic Use                         

  6.1.3.5 By End-user

                                6.1.4  Market Attractiveness Analysis                                     

  6.1.4.1 By Geographical Area                     

  6.1.4.2 By Device Type                  

  6.1.4.3 By Formulation                  

  6.1.4.4 By Therapeutic Use                         

  6.1.4.5 By End-user

                                6.1.5  Market Share Analysis                                      

  6.1.5.1 By Geographical Area                     

  6.1.5.2 By Device Type                  

  6.1.5.3 By Formulation                  

  6.1.5.4 By Therapeutic Use                         

  6.1.5.5 By End-user

                6.2 Middle-East            

                6.3 Africa        

7.Strategic Analysis                    

                7.1 PESTLE analysis     

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis          

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                     

                8.1 Alkermes Inc.        

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Bend Research      

                8.3 BIND Biosciences Inc.         

                8.4 Endocyte 

                8.5 Genentech Inc.     

                8.6 MicroCHIPS Inc.    

                8.7 Pearl Therapeutics Inc.      

                8.8 Polymer Factory   

                8.9 Presage Bioscience   

                8.10  QLT Inc. 

                8.11 UCB Group.          

9.Competitive Landscape                        

                9.1 Market share analysis        

                9.2 Merger and Acquisition Analysis   

                9.3 Agreements, collaborations and Joint Ventures     

                9.4 New Product Launches     

10.Market Outlook and Investment Opportunities                      

Appendix                       

                a) List of Tables  

                b) List of Figures          

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  2. Middle East & Africa Self-injection Devices Market By Region, From 2019-2024 ( USD Million )
  3. Middle East & Africa Conventional Devices Market By Region, From 2019-2024 ( USD Million )
  4. Middle East & Africa Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  5. Middle East & Africa Conventional Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  6. Middle East & Africa Novel Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  7. Middle East & Africa Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  8. Middle East & Africa Autoimmune Disorders Market By Region, From 2019-2024 ( USD Million )
  9. Middle East & Africa Hormonal Disorders Market By Region, From 2019-2024 ( USD Million )
  10. Middle East & Africa Oncology Market By Region, From 2019-2024 ( USD Million )
  11. Middle East & Africa Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  12. Middle East & Africa Hospitals Market By Region, From 2019-2024 ( USD Million )
  13. Middle East & Africa Homecare Settings Market By Region, From 2019-2024 ( USD Million )
  14. Middle East & Africa Research Institutes Market By Region, From 2019-2024 ( USD Million )
  15. Middle East & Africa Clinical Laboratories Market By Region, From 2019-2024 ( USD Million )
  16. Middle East Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  17. Middle East Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  18. Middle East Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  19. Middle East Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  20. Africa Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  21. Africa Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  22. Africa Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  23. Africa Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample